Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
3.460
-0.015 (-0.43%)
At close: Oct 22, 2024, 4:00 PM
3.520
+0.060 (1.73%)
After-hours: Oct 22, 2024, 6:31 PM EDT

Rockwell Medical Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Rockwell Medical stock has a target of 9.00, which predicts an increase of 160.12% from the current stock price of 3.46.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $9.00 $9.00 $9.00 $9.00
Change +160.12% +160.12% +160.12% +160.12%
* Price targets were last updated on Sep 11, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for RMTI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 222221
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +160.12% Sep 11, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +160.12% Sep 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +160.12% Aug 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +160.12% May 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11$9
Strong Buy Maintains $11$9 +160.12% Mar 25, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
102.17M
from 83.61M
Increased by 22.20%
Revenue Next Year
111.12M
from 102.17M
Increased by 8.76%
EPS This Year
-0.03
from -0.37
EPS Next Year
0.07
from -0.03
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
61.30M62.20M61.93M72.81M83.61M102.17M111.12M
Revenue Growth
-3.29%1.46%-0.43%17.57%14.84%22.20%8.76%
EPS
-6.16-4.49-3.83-1.31-0.37-0.030.07
EPS Growth
-------
Forward PE
------48.46
No. Analysts -----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 106.6M 116.2M
Avg 102.2M 111.1M
Low 96.8M 105.1M

Revenue Growth

Revenue Growth 20242025
High
27.5%
13.7%
Avg
22.2%
8.8%
Low
15.8%
2.9%

EPS Forecast

EPS 20242025
High -0.03 0.07
Avg -0.03 0.07
Low -0.03 0.07

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.